Morgan Stanley Corcept Therapeutics Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Morgan Stanley holds 1,458,495 shares of CORT stock, worth $86.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,458,495

Previous 1,315,579 10.86%

Holding current value

$86.1 Million

Previous $42.7 Million 57.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$29.51 - $46.26 $4.22 Million - $6.61 Million	142,916 Added 10.86%	1,458,495 $67.5 Million
Q2 2024 Oct 17, 2024	SELL	$22.21 - $34.48 $4.39 Million - $6.81 Million	-197,499 Reduced 13.05%	1,315,579 $42.7 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $4.39 Million - $6.81 Million	-197,499 Reduced 13.05%	1,315,579 $42.7 Million
Q1 2024 Oct 17, 2024	BUY	$21.1 - $27.46 $4.17 Million - $5.42 Million	197,499 Added 15.01%	1,513,078 $38.1 Million
Q1 2024 Aug 16, 2024	BUY	$21.1 - $27.46 $4.58 Million - $5.96 Million	216,942 Added 16.74%	1,513,078 $38.1 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $4.58 Million - $5.96 Million	216,942 Added 16.74%	1,513,078 $38.1 Million
Q4 2023 Aug 16, 2024	SELL	$24.82 - $32.88 $482,575 - $639,285	-19,443 Reduced 1.48%	1,296,136 $42.1 Million
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $1.76 Million - $2.34 Million	71,089 Added 5.8%	1,296,136 $42.1 Million
Q3 2023 Nov 15, 2023	BUY	$21.97 - $33.8 $6.5 Million - $10 Million	296,015 Added 31.86%	1,225,047 $33.4 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $3.27 Million - $3.83 Million	152,355 Added 19.62%	929,032 $20.7 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $5.92 Million - $7.54 Million	-308,147 Reduced 28.41%	776,677 $16.8 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $1.42 Million - $2.13 Million	-71,172 Reduced 6.16%	1,084,824 $22 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $4.67 Million - $5.5 Million	189,014 Added 19.55%	1,155,996 $29.6 Million
Q2 2022 Oct 27, 2022	BUY	$17.33 - $25.3 $2.46 Million - $3.59 Million	142,088 Added 17.23%	966,982 $23 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $2.46 Million - $3.59 Million	142,088 Added 17.23%	966,982 $23 Million
Q1 2022 Oct 27, 2022	SELL	$16.53 - $25.21 $2.35 Million - $3.58 Million	-142,088 Reduced 14.69%	824,894 $18.6 Million
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $2.05 Million - $3.12 Million	123,885 Added 17.67%	824,894 $18.6 Million
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $603,732 - $824,042	-35,306 Reduced 4.79%	701,009 $13.9 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $14.5 Million - $16.6 Million	736,315 New	736,315 $14.5 Million

Others Institutions Holding CORT

# of Institutions

349

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.32B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account